JAZZ 250516 110.00C(JAZZ250516C110000) Stock Price Today | Quotes & News - Moomoo

US OptionsDetailed Quotes

JAZZ250516C110000

Watchlist

5.70
-3.63-38.91%

15min DelayClose May 6 16:00 ET

6.90High5.70Low

Intraday

5D
Daily

News

Jazz Q1 Earnings, Revenue Decline; Updates Outlook
MT Newswires17:04 ET
TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $205
Moomoo News45minutes ago · Ratings
Earnings Call Summary | Jazz Pharmaceuticals(JAZZ.US) Q1 2025 Earnings Conference
moomoo AI23:13 ET · Conference Call
Jazz Outlines $4.15B-$4.4B Revenue Target for 2025 Amid Growth in Neuroscience Portfolio and New Oncology Approvals
Seeking Alpha23:07 ET
Express News | Jazz Pharmaceuticals PLC : Piper Sandler Cuts Target Price to $147 From $176
Reuters22:50 ET
Optimistic Buy Rating for Jazz Pharmaceuticals Amid Growth Prospects and Strategic Positioning
TipRanks22:25 ET · Ratings

Comments

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

$Jazz Pharmaceuticals (JAZZ.US)$
Breakthrough: EU Panel Endorses First-Ever HER2 Treatment for Rare Biliary Cancer - What This Means for Patients

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse

$Jazz Pharmaceuticals (JAZZ.US)$
Major Cancer Breakthrough: New Phase 3 Data Reveals Significant Survival Benefits in Lung Cancer Treatment

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse

$Jazz Pharmaceuticals (JAZZ.US)$ What happened with this stock? Why did it go down so much?

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

$Jazz Pharmaceuticals (JAZZ.US)$ $Chimerix(Delisted) (CMRX.US)$
Can Jazz's $935M Chimerix Acquisition Transform Rare Brain Tumor Treatment? FDA Decision Looms

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

1

$Jazz Pharmaceuticals (JAZZ.US)$ just so you all know that this and $Sarepta Therapeutics (SRPT.US)$ are in the same area as $Cumberland Pharmaceuticals (CPIX.US)$ if you wanna know where CPIX price will be in the future

1

Read more